Abstract Details

Title A Long-term Blinded Controlled Efficacy Study of SNT-MC17/Idebenone in the Dystrophin-Deficient MDX Mouse

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 012

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Gunnar Buyse, MD, PhD (University Hospitals K.U. Leuven)	No disclosure on file
	No disclosure on file
Shefali Dujari, MD (Stanford University School of Medicine)	Dr. Dujari has nothing to disclose.
	No disclosure on file
Michael Erb	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Thomas Meier, PhD (Santhera Pharmaceuticals)	No disclosure on file

��ɫ����